2,4'-Dibromoacetophenone - 98%, high purity , CAS No.99-73-0

  • ≥98%
Item Number
D113568
Grouped product items
SKUSizeAvailabilityPrice Qty
D113568-5g
5g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$9.90
D113568-25g
25g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$29.90
D113568-100g
100g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$81.90
D113568-500g
500g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$292.90

Basic Description

Synonyms2,4'-Dibromoacetophenone, >98% | STL069069 | 2,4'-Dibromoacetophenone, for HPLC derivatization, >=99.0% (HPLC) | .alpha.,para-Dibromoacetophenone | 2,4'-dibromo acetophenone | Halomethyl Phenyl Ketone deriv. 24 | 4-BPB | BP-20195 | CCRIS 3623 | MFCD000002
Specifications & Purity≥98%
Storage TempStore at 2-8°C,Protected from light
Shipped InWet ice
Product Description

GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&beta); (IC = 0.5 μM). This compound acts as an alkylating agent that is selective towards GSK-3β and does not affect PKA activity even at concentrations as high as 100 μM. Research has shown that glycogen synthase kinases have major roles in Wnt and Hedgehog signaling pathways and regulate the cell-division cycle, stem-cell renewal and differentiation, apoptosis, circadian rhythm, transcription and insulin action. This pertinent biological activity makes GSK inhibitors very useful research molecules.
A cell-permeable, and non-ATP competitive inhibitor of GSK-3β


Application:

Undergoes condensation reactions with aldehydes in the presence of SnCl2 or SmI3 to afford α,β-unsaturated ketones. Also useful in the esterification of carboxylic acids.

Associated Targets(Human)

DRD2 Tclin D(2) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EGFR Tclin Epidermal growth factor receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SRC Tclin Proto-oncogene tyrosine-protein kinase Src (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CAMKK2 Tchem Calcium/calmodulin-dependent protein kinase kinase 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PRKACB Tchem cAMP-dependent protein kinase catalytic subunit beta (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD3 Tclin D(3) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM5 Tclin Muscarinic acetylcholine receptor M5 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2C Tclin Alpha-2C adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ABL1 Tclin Tyrosine-protein kinase ABL1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GSK3B Tclin Glycogen synthase kinase-3 beta (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
INSR Tclin Insulin receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAPK1 Tchem Mitogen-activated protein kinase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAP2K1 Tclin Dual specificity mitogen-activated protein kinase kinase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K1 Tclin Dual specificity mitogen-activated protein kinase kinase 1 (4127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mapk1 Mitogen-activated protein kinase 1 (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Camkk2 Calcium/calmodulin-dependent protein kinase kinase 2 (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic acetylcholine receptor (3770 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra2c Adrenergic receptor alpha-2 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 2-bromo-1-(4-bromophenyl)ethanone
INCHI InChI=1S/C8H6Br2O/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4H,5H2
InChi Key FKJSFKCZZIXQIP-UHFFFAOYSA-N
Canonical SMILES C1=CC(=CC=C1C(=O)CBr)Br
Isomeric SMILES C1=CC(=CC=C1C(=O)CBr)Br
WGK Germany 2
RTECS AM6950000
PubChem CID 7454
UN Number 3261
Packing Group II
Molecular Weight 277.94
Beilstein 607604
Reaxy-Rn 607604

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

20 results found

Lot NumberCertificate TypeDateItem
J2425217Certificate of AnalysisJul 05, 2024 D113568
I2411512Certificate of AnalysisJul 05, 2024 D113568
I2411508Certificate of AnalysisJul 05, 2024 D113568
I2201314Certificate of AnalysisJun 14, 2024 D113568
I2201120Certificate of AnalysisJun 14, 2024 D113568
I2201111Certificate of AnalysisJun 14, 2024 D113568
A2426465Certificate of AnalysisJan 15, 2024 D113568
G2401062Certificate of AnalysisJan 15, 2024 D113568
A2426479Certificate of AnalysisJan 15, 2024 D113568
A2426478Certificate of AnalysisJan 15, 2024 D113568
A2426477Certificate of AnalysisJan 15, 2024 D113568
A2426472Certificate of AnalysisJan 15, 2024 D113568
A2426471Certificate of AnalysisJan 15, 2024 D113568
A2426467Certificate of AnalysisJan 15, 2024 D113568
A2426464Certificate of AnalysisJan 15, 2024 D113568
J2129478Certificate of AnalysisAug 17, 2023 D113568
J2129479Certificate of AnalysisAug 17, 2023 D113568
J2129484Certificate of AnalysisAug 17, 2023 D113568
L2031189Certificate of AnalysisOct 19, 2022 D113568
I2201125Certificate of AnalysisJul 21, 2022 D113568

Show more⌵

Chemical and Physical Properties

SolubilitySoluble in DMSO (5 mg/ml), methanol (20 mg/ml), toluene, and ethanol. Insoluble in water.
Sensitivityheat and light sensitive
Melt Point(°C)108-110°C

Safety and Hazards(GHS)

Pictogram(s) GHS05
Signal Danger
Hazard Statements

H314:Causes severe skin burns and eye damage

H303:May be harmful if swallowed

Precautionary Statements

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P301+P330+P331:IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P363:Wash contaminated clothing before reuse.

P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing.

P302+P361+P354:IF ON SKIN: Take off Immediately all contaminated clothing. Immediately rinse with water for several minutes.

P316:Get emergency medical help immediately.

WGK Germany 2
RTECS AM6950000
Reaxy-Rn 607604
Merck Index 1427

Related Documents

References

1. P S F Barbosa,A M C Martins,A Havt,Daniela O Toyama,J S A M Evangelista,D P P Ferreira,P P Joazeiro,Luis O S Beriam,Marcos H Toyama,M C Fonteles,H S A Monteiro.  (2005-08-24)  Renal and antibacterial effects induced by myotoxin I and II isolated from Bothrops jararacussu venom..  Toxicon : official journal of the International Society on Toxinology,  46  ((4)): (376-386).  [PMID:16115661]
2. Christopher L Sprague,Adnan A Elfarra.  (2005-09-01)  Protection of rats against 3-butene-1,2-diol-induced hepatotoxicity and hypoglycemia by N-acetyl-l-cysteine..  Toxicology and applied pharmacology,  207  ((3)): (266-274).  [PMID:16129119]
3. Sanjaya Kuruppu,Shane Reeve,Yajnavalka Banerjee,R Manjunatha Kini,A Ian Smith,Wayne C Hodgson.  (2005-09-02)  Isolation and pharmacological characterization of cannitoxin, a presynaptic neurotoxin from the venom of the Papuan Taipan (Oxyuranus scutellatus canni)..  The Journal of pharmacology and experimental therapeutics,  315  ((3)): (1196-1202).  [PMID:16135698]
4. Youngjin Park,A R Nor Aliza,David Stanley.  (2005-10-20)  A secretory PLA2 associated with tobacco hornworm hemocyte membrane preparations acts in cellular immune reactions..  Archives of insect biochemistry and physiology,  60  ((3)): (105-115).  [PMID:16235259]
5. Angelo J Magro,Agnes A S Takeda,Andreimar M Soares,Marcos R M Fontes.  (2005-11-23)  Structure of BthA-I complexed with p-bromophenacyl bromide: possible correlations with lack of pharmacological activity..  Acta crystallographica. Section D, Biological crystallography,  61  ((Pt 12)): (1670-1677).  [PMID:16301802]
6. Taomin Huang,Zhong He,Bei Yang,Luping Shao,Xiaowei Zheng,Gengli Duan.  (2006-01-18)  Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution..  Journal of pharmaceutical and biomedical analysis,  41  ((2)): (644-648).  [PMID:16413728]
7. D P Marchi-Salvador,C A H Fernandes,S F Amui,A M Soares,M R M Fontes.  (2006-06-07)  Crystallization and preliminary X-ray diffraction analysis of a myotoxic Lys49-PLA2 from Bothrops jararacussu venom complexed with p-bromophenacyl bromide..  Acta crystallographica. Section F, Structural biology and crystallization communications,  62  ((Pt 6)): (600-603).  [PMID:16754993]
8. Lei Wang,Wolfgang Armbruster,Dieter Jendrossek.  (2007-04-03)  Production of medium-chain-length hydroxyalkanoic acids from Pseudomonas putida in pH stat..  Applied microbiology and biotechnology,  75  ((5)): (1047-1053).  [PMID:17401563]
9. Johanna Mansfeld,Renate Ulbrich-Hofmann.  (2007-08-19)  Secretory phospholipase A2-alpha from Arabidopsis thaliana: functional parameters and substrate preference..  Chemistry and physics of lipids,  150  ((2)): (156-166).  [PMID:17692835]
10. Xiao-Wang Qu,Wen-Pei Liu,Zheng-Yu Qi,Zhao-Jun Duan,Li-Shu Zheng,Zi-Zhou Kuang,Wan-Ju Zhang,Yun-De Hou.  (2007-11-06)  Phospholipase A2-like activity of human bocavirus VP1 unique region..  Biochemical and biophysical research communications,  365  ((1)): (158-163).  [PMID:17981142]
11. Heiki Vija,Mari Samel,Ene Siigur,Anu Aaspõllu,Katrin Trummal,Külli Tõnismägi,Juhan Subbi,Jüri Siigur.  (2009-05-27)  Purification, characterization, and cDNA cloning of acidic platelet aggregation inhibiting phospholipases A(2) from the snake venom of Vipera lebetina (Levantine viper)..  Toxicon : official journal of the International Society on Toxinology,  54  ((4)): (429-439).  [PMID:19467252]
12. Daniela P Marchi-Salvador,Carlos A H Fernandes,Lucas B Silveira,Andreimar M Soares,Marcos R M Fontes.  (2009-07-21)  Crystal structure of a phospholipase A(2) homolog complexed with p-bromophenacyl bromide reveals important structural changes associated with the inhibition of myotoxic activity..  Biochimica et biophysica acta,  1794  ((11)): (1583-1590).  [PMID:19616648]
13. Mark Merchant,Raphiel Heard,Caleb Monroe.  (2009-07-31)  Characterization of phospholipase A(2) activity in serum of the American alligator (Alligator mississippiensis)..  Journal of experimental zoology. Part A, Ecological genetics and physiology,  311  ((9)): (662-666).  [PMID:19642205]
14. Sandeep Ravindran,Melissa B Lodoen,Steven H L Verhelst,Matthew Bogyo,John C Boothroyd.  (2009-12-04)  4-Bromophenacyl bromide specifically inhibits rhoptry secretion during Toxoplasma invasion..  PloS one,  ((12)): (e8143-e8143).  [PMID:19956582]
15. Sony Shrestha,Yonggyun Kim.  (2010-02-04)  Biochemical characteristics of immune-associated phospholipase A(2) and its inhibition by an entomopathogenic bacterium, Xenorhabdus nematophila..  Journal of microbiology (Seoul, Korea),  47  ((6)): (774-782).  [PMID:20127473]
16. Markus Berger,José Reck,Renata M S Terra,Walter O Beys da Silva,Lucélia Santi,Antônio F M Pinto,Marilene H Vainstein,Carlos Termignoni,Jorge A Guimarães.  (2010-02-17)  Lonomia obliqua venomous secretion induces human platelet adhesion and aggregation..  Journal of thrombosis and thrombolysis,  30  ((3)): (300-310).  [PMID:20157842]
17. Karinne Cristinne da Silva Cunha,André Lopes Fuly,Elizabeth Giestal de Araujo.  (2011-01-13)  A phospholipase A₂ isolated from Lachesis muta snake venom increases the survival of retinal ganglion cells in vitro..  Toxicon : official journal of the International Society on Toxinology,  57  ((4)): (580-585).  [PMID:21223976]
18. Daniel I Perez, Valle Palomo, Concepción Pérez, Carmen Gil, Pablo D Dans, F Javier Luque, Santiago Conde, Ana Martínez,.  (2011-04-20)  Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds..  Journal of medicinal chemistry,  54  ((12)): ( 4042-4056 ).  [PMID:21500862]
19. Zhuo-Jia Chen,Xue-Ding Wang,Hong-Sheng Wang,Shu-da Chen,Lie-Min Zhou,Jia-Li Li,Wen-Ying Shu,Jue-Qian Zhou,Zi-Yan Fang,Yu Zhang,Min Huang.  (2011-11-08)  Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy..  Seizure,  21  ((2)): (110-117).  [PMID:22055352]
20. He-ying Liu,Li Ding,Yong Yu,Yan Chu,He Zhu.  (2012-03-21)  Comparison of three derivatization reagents for the simultaneous determination of highly hydrophilic pyrimidine antitumor agents in human plasma by LC-MS/MS..  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,  893-894  (49-56).  [PMID:22429875]
21. Rafael M Ximenes,Renata S Alves,Ticiana P Pereira,Renata M Araújo,Edilberto R Silveira,Marcelo M Rabello,Marcelo Z Hernandes,Veronica C G Soares,Daniel Bristot,Camila L Pires,Daniela O Toyama,Henrique H Gaeta,Helena S A Monteiro,Marcos H Toyama.  (2012-08-29)  Harpalycin 2 inhibits the enzymatic and platelet aggregation activities of PrTX-III, a D49 phospholipase A2 from Bothrops pirajai venom..  BMC complementary and alternative medicine,  12  (139-139).  [PMID:22925825]
22. Mariana A P Rodrigues,Lourdes Dias,André L Rennó,Norma C Sousa,Adriana Smaal,Delano A da Silva,Stephen Hyslop.  (2014-06-29)  Rat atrial responses to Bothrops jararacussu (jararacuçu) snake venom..  Toxicology,  323  (109-124).  [PMID:24973630]
23. Wan Chen,Leng Chuan Goh,Tse Siang Kang,R Manjunatha Kini.  (2014-07-11)  Identification and characterisation of novel inhibitors on extrinsic tenase complex from Bungarus fasciatus (banded krait) venom..  Thrombosis and haemostasis,  112  ((4)): (700-715).  [PMID:25008365]
24. Jordan Doumanov,Kirilka Mladenova,Tanya Topouzova-Hristova,Stoyanka Stoitsova,Svetla Petrova.  (2014-12-24)  Effects of vipoxin and its components on HepG2 cells..  Toxicon : official journal of the International Society on Toxinology,  94  (36-44).  [PMID:25534906]
25. J Fohlman,D Eaker,M J Dowdall,R Lüllmann-Rauch,T Sjödin,S Leander.  (1979-03-01)  Chemical modification of taipoxin and the consequences for phospholipase activity, pathophysiology, and inhibition of high-affinity choline uptake..  European journal of biochemistry,  94  ((2)): (531-540).  [PMID:428399]
26. H M Verheij,J J Volwerk,E H Jansen,W C Puyk,B W Dijkstra,J Drenth,G H de Haas.  (1980-02-19)  Methylation of histidine-48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism..  Biochemistry,  19  ((4)): (743-750).  [PMID:7356955]
27. C C Yang,K King.  (1980-08-07)  Chemical modification of the histidine residue in basic phospholipase A2 from the venom of Naja nigricollis..  Biochimica et biophysica acta,  614  ((2)): (373-388).  [PMID:7407195]
28. Adriana G Martins,Jorgete Constantin,Fabrício Bracht,Ana Maria Kelmer-Bracht,Adelar Bracht.  (2006-05-03)  The action of extracellular NAD+ on gluconeogenesis in the perfused rat liver..  Molecular and cellular biochemistry,  286  ((1-2)): (115-124).  [PMID:16652226]
29. Mohammad Tariq,Ibrahim Elfaki,Haseeb-Ahmad Khan,Mohammad Arshaduddin,Samia Sobki,Meshal Al Moutaery.  (2006-09-29)  Bromophenacyl bromide, a phospholipase A2 inhibitor attenuates chemically induced gastroduodenal ulcers in rats..  World journal of gastroenterology,  12  ((36)): (5798-5804).  [PMID:17007045]
30. Wen-Hsin Liu,Pei-Hsiu Kao,Yi-Ling Chiou,Shinne-Ren Lin,Ming-Jung Wu,Long-Sen Chang.  (2009-01-03)  Catalytic activity-independent pathway is involved in phospholipase A(2)-induced apoptotic death of human leukemia U937 cells via Ca(2+)-mediated p38 MAPK activation and mitochondrial depolarization..  Toxicology letters,  185  ((2)): (102-109).  [PMID:19118607]

Solution Calculators